292. June in Medtech: $700M in Deals, Medtronic’s Strategic Exit & LSI Highlights

Episode breakdown:00:00 – What June’s headlines missed 01:44 – Why Medtronic exited another business unit 05:02 – The quiet strategy behind “focus” 08:20 – $700M in deal volume: Who’s buying, who’s scaling 09:56 – LSI 2024: What we learned on the ground 13:33 – GTM strategy shifts in diagnostics and devices 15:41 – Private equity’s next move in medtech 18:23 – Boston Scientific’s bet and others to watch 20:10 – Key signals investors are paying attention to 22:50 – Where AI is winning—beyond the hype 26:17 – Medtech’s Q3 setup: what matters next**Learn more about LSI’s market intel platform and amazing investor summits at LS-Intel.com**Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to [GrowMyMedtech.com](http://GrowMyMedtech.com) to book time for a free analysis. Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/the-state-of-medtech-6863578381842288641/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#medicadevices #medicalsales #medtech #medicalsalesrep #pharmasales #medicaldeviceThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.